Linfomas
GLUN
Humanitas University
Rozzano, ItaliaPublications in collaboration with researchers from Humanitas University (2)
2023
2021
-
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma
Investigational New Drugs, Vol. 39, Núm. 4, pp. 1028-1035